Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L LaMattina

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Medicine|February 7, 2009
Disease mongering is a mythJohn L LaMattina
Nature Reviews. Drug Discovery|August 2, 2011
The impact of mergers on pharmaceutical R&DJohn L LaMattina
Nature Reviews. Drug Discovery|May 3, 2005
An audience with... John L. LaMattinaJohn L LaMattina
Science (New York, N.Y.)|February 25, 2017
Approving new drugsJohn L LaMattina
Nature Reviews. Drug Discovery|January 31, 2015
A plan for sustainable funding for US biomedical researchPreston Hensley, John L LaMattina
JAMA Oncology|July 9, 2016
Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment ModelThomas J Hwang, John L LaMattina
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Medicine|February 7, 2009
Disease mongering is a mythJohn L LaMattina
Nature Reviews. Drug Discovery|August 2, 2011
The impact of mergers on pharmaceutical R&DJohn L LaMattina
Nature Reviews. Drug Discovery|May 3, 2005
An audience with... John L. LaMattinaJohn L LaMattina
Science (New York, N.Y.)|February 25, 2017
Approving new drugsJohn L LaMattina
Nature Reviews. Drug Discovery|January 31, 2015
A plan for sustainable funding for US biomedical researchPreston Hensley, John L LaMattina
JAMA Oncology|July 9, 2016
Measuring the Value of New Medications and Implications for Medicare's Proposed Part B Drug Payment ModelThomas J Hwang, John L LaMattina
Pageof 1